{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:54:57Z","timestamp":1792896897071,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1141295"],"award-info":[{"award-number":["APP1141295"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejso.2022.01.021","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T03:08:51Z","timestamp":1644635331000},"page":"1280-1287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)"],"prefix":"10.1016","volume":"48","author":[{"given":"Alistair J.","family":"Cochran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan-Ren","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Abrishami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-0013","authenticated-orcid":false,"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2816-2496","authenticated-orcid":false,"given":"John F.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Van Kreuningen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9706-1499","authenticated-orcid":false,"given":"Myung-Shin","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Faries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kirkwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mihm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshal","family":"Urist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Beegun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2022.01.021_bib1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2022.01.021_bib2","series-title":"AJCC cancer staging manual","first-page":"563","article-title":"Melanoma of the skin","author":"Gershenwald","year":"2017"},{"key":"10.1016\/j.ejso.2022.01.021_bib3","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","article-title":"Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline","volume":"30","author":"Wong","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.6004\/jnccn.2019.0018","article-title":"Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in Oncology","volume":"17","author":"Coit","year":"2019","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2022.01.021_bib5","series-title":"Clinical practice guidelines for the management of melanoma in Australia and New Zealand","first-page":"73","author":"AustralianCancerNetwork","year":"2008"},{"key":"10.1016\/j.ejso.2022.01.021_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1245\/s10434-017-6267-7","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American society of clinical Oncology and society of surgical Oncology clinical practice guideline update","volume":"25","author":"Wong","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.01.021_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.annonc.2020.11.015","article-title":"Sentinel node biopsy in patients with melanoma improves the accuracy of staging when added to clinicopathological features of the primary tumor","volume":"32","author":"El Sharouni","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000478-198907000-00008","article-title":"Histomorphometry in the assessment of prognosis in stage II malignant melanoma","volume":"13","author":"Cochran","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2022.01.021_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/modpathol.3800117","article-title":"Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node","volume":"17","author":"Cochran","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2022.01.021_bib10","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.0.CO;2-Q","article-title":"A\u00a0micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma","volume":"91","author":"Starz","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.01.021_bib11","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1245\/s10434-007-9472-y","article-title":"Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma","volume":"14","author":"Scheri","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1245\/s10434-007-9767-z","article-title":"Isolated tumor cells and long-term prognosis of patients with melanoma","volume":"15","author":"van Akkooi","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib13","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1200\/JCO.2004.12.177","article-title":"The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement","volume":"22","author":"Dewar","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10434-999-0398-4","article-title":"Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma","volume":"6","author":"Wagner","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib15","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1245\/s10434-006-9241-3","article-title":"Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse","volume":"14","author":"Govindarajan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib16","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1309\/TDWJTR15TDM1TG7Q","article-title":"Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma","volume":"122","author":"Scolyer","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ejso.2022.01.021_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/SLA.0b013e3181b1735b","article-title":"Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node","volume":"250","author":"van der Ploeg","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.01.021_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/path.1710970305","article-title":"Histology and prognosis in malignant melanoma","volume":"97","author":"Cochran","year":"1969","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ejso.2022.01.021_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00000658-198207000-00015","article-title":"Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes","volume":"196","author":"Callery","year":"1982","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.01.021_bib20","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American joint committee on cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2022.01.021_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","article-title":"Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an interanational multicenter trial","volume":"242","author":"Morton","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2022.01.021_bib23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejso.2022.01.021_bib24","doi-asserted-by":"crossref","DOI":"10.1245\/ASO.2004.12.923","article-title":"Optimized assessment of sentinel lymph nodes for metastatic melanoma: implications for regional surgery and overall treatment planning","volume":"11","author":"Cochran","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jso.21818","article-title":"Clinically relevant information from sentinel lymph node biopsies of melanoma patients","volume":"104","author":"Wen","year":"2011","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib26","first-page":"102","article-title":"Pathological evaluation of the regional lymph nodes in malignant melanoma","volume":"10","author":"Robert","year":"1993","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.ejso.2022.01.021_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrclinonc.2010.100","article-title":"Importance of tumor load in the sentinel node in melanoma: clinical dilemmas","volume":"7","author":"van Akkooi","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib28","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2022.01.021_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2013.08.023","article-title":"The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients","volume":"50","author":"van der Ploeg","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2022.01.021_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jamcollsurg.2013.12.014","article-title":"Comparison of sentinel lymph node micrometastatic tumor burden measurements in melanoma","volume":"218","author":"Egger","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2022.01.021_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.cmr.0000136708.90534.71","article-title":"Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens","volume":"14","author":"Scolyer","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejso.2022.01.021_bib32","first-page":"100","article-title":"Evaluation of melanoma in non-sentinel nodes: how much is enough?","volume":"17","author":"Wen","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejso.2022.01.021_bib33","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2022.01.021_bib34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","article-title":"Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial","volume":"17","author":"Leiter","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa2005493","article-title":"Five-year analysis of adjuvant Dabrafenib plus Trametinib in stage III melanoma","volume":"383","author":"Dummer","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2022.01.021_bib36","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S1470-2045(20)30494-0","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial","volume":"21","author":"Ascierto","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1245\/ASO.2005.06.013","article-title":"Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma","volume":"12","author":"Vuylsteke","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib38","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1365-2559.2007.02681.x","article-title":"Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients","volume":"50","author":"Satzger","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2022.01.021_bib39","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1200\/JCO.2007.15.4179","article-title":"Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma","volume":"26","author":"Gershenwald","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.01.021_bib40","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1200\/JCO.2010.30.9567","article-title":"Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes","volume":"28","author":"Murali","year":"2010","journal-title":"J\u00a0Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322000476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:42:30Z","timestamp":1760060550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322000476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0748798322000476"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.021","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}